Email This Article
Headlines & Perspectives
Health Winners & Losers: Merck
By
Elizabeth Trotta
05/14/08 - 04:11 PM EDT
Genzyme climbs on a Wall Street upgrade.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.




View Directory